Alert detail
FDA Approval: VORANIGO (VORASIDENIB) — Type 1 - New Molecular Entity
Policy ID: FDA-NDA218784Specialty: OncologyAdded: 6/13/2026Effective: 2024-08-06federal register
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.